Ziopharm Oncology Appoints Heidi Hagen to Board of Directors

BOSTON, June 17, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. ("Ziopharm" or "the Company") (Nasdaq:ZIOP), today announced Heidi Hagen, an experienced and entrepreneurial biotechnology operations executive, has been appointed to the Company's Board of Directors effective immediately...
Login to comment.